Patents by Inventor Rama Kishore V P PUTTA

Rama Kishore V P PUTTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
    Patent number: 11629135
    Abstract: The compounds of Formula Ib, Formula Ia, and Formula I are described herein along with their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof. The process of preparation of the compounds of Formula Ib, Formula Ia, and Formula I is also described. The compounds described herein, their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof are 2-(benzyloxy)pyrimidine derivatives that are inhibitors of PD-1/PD-L1 activation.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: April 18, 2023
    Assignee: JUBILANT PRODELL LLC
    Inventors: Chandregowda Venkateshappa, Athisayamani Jeyaraj Duraiswamy, Rama Kishore V P Putta, Sridharan Rajagopal
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING FIBROSIS
    Publication number: 20220098214
    Abstract: The present invention provides compounds and methods for treating MKP5 modulated disease. In certain embodiments, the MKP5 modulated disease is a fibrotic disease.
    Type: Application
    Filed: January 30, 2020
    Publication date: March 31, 2022
    Inventors: Anton BENNETT, Gurulingappa HALLUR, Chandregowda VENKATESHAPPA, Athisayamani Jeyaraj DURAISWAMY, Rama Kishore V.P. PUTTA
  • PYRIMIDINE DERIVATIVES AS INHIBITORS OF PD1/PD-L1 ACTIVATION
    Publication number: 20210179580
    Abstract: The compounds of Formula Ib, Formula Ia, and Formula I are described herein along with their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof. The process of preparation of the compounds of Formula Ib, Formula Ia, and Formula I is also described. The compounds described herein, their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof are 2-(benzyloxy)pyrimidine derivatives that are inhibitors of PD-1/PD-L1 activation.
    Type: Application
    Filed: November 6, 2018
    Publication date: June 17, 2021
    Inventors: Chandregowda VENKATESHAPPA, Athisayamani Jeyaraj DURAISWAMY, Rama Kishore V P PUTTA, Sridharan RAJAGOPAL